Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment source : Investor.aveooncology.com save search
U.S. Patent & Trademark Office Allows AVEO Oncology’s Patent Application Covering Use of FOTIVDA® for the Treatment of Refractory Advanced Renal Cell Carcinoma
Published: 2022-10-12 (Crawled : 21:00) - investor.aveooncology.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: -4.1%
H: 0.0%
C: 0.0%
fotivda treatment patent application renal cell carcinoma
AVEO Oncology Announces Updated NCCN Clinical Practice Guidelines Elevate FOTIVDA® (tivozanib) to Category 1 Treatment for Relapsed or Refractory Advanced (R/R) Renal Cell Carcinoma (RCC) Patients
Published: 2022-06-21 (Crawled : 12:00) - investor.aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 5.09%
H: 0.0%
C: 0.0%
fotivda guidelines treatment renal cell carcinoma
AVEO Oncology Announces Ficlatuzumab Granted Fast Track Designation by the U.S. FDA for the Treatment of Relapsed or Recurrent Head and Neck Squamous Cell Carcinoma
Published: 2021-09-20 (Crawled : 11:00) - investor.aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 4.34%
H: 0.0%
C: -5.17%
treatment fda fast track granted fast track designation designation cell carcinoma
AVEO Oncology Announces U.S. Commercial Availability of FOTIVDA® (tivozanib) for the Treatment of Adult Patients With Relapsed or Refractory Advanced Renal Cell Carcinoma Ahead of Previous Guidance
Published: 2021-03-22 (Crawled : 11:00) - investor.aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 5.67%
H: 0.0%
C: -5.91%
treatment renal commercialization cell carcinoma
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.